HyperPATH study cohort for all variables

Published: 21 November 2024| Version 1 | DOI: 10.17632/h588hz3pbt.1
Contributor:
Ezgi Caliskan Guzelce

Description

International Hypertensive Pathotype (HyperPATH) Consortium, HyperPATH study, has been an on-going, multi-site study, aimed at investigating the pathophysiologic and genotypic mechanisms involved in hypertension and cardiovascular diseases. Participants were studied at four collaborating centers: Brigham and Women’s Hospital (Boston, MA), University of Utah Medical Center (Salt Lake City, UT), Vanderbilt University Hospital (Nashville, TN), and Hôpital Européen Georges Pompidou (Paris, France).

Files

Institutions

  • Harvard Medical School
  • Harvard University

Categories

Cardiovascular Endocrinology, Sex Differentiation, Hypertension, Aldosterone

Licence